Cargando…
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
With increasing frequency, humans are facing outbreaks of emerging infectious diseases (EIDs) with the potential to cause significant morbidity and mortality. In the most extreme instances, such outbreaks can become pandemics, as we are now witnessing with COVID-19. According to the World Health Org...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473320/ https://www.ncbi.nlm.nih.gov/pubmed/32579067 http://dx.doi.org/10.1080/22221751.2020.1787108 |